Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), a specialty pharmaceutical company, focuses their efforts on identifying, developing and commercializing innovative products designed to address unmet medical needs in neurology and psychiatry. Their goal as a company is to develop a broad portfolio of products through internal development and acquisition/in-licensing while utilizing a specialty sales force to promote products in target markets. For further information, visit the Company’s web site at www.jazzpharmaceuticals.com.
- 17 years ago
QualityStocks
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Venture Begins Clinical Trials of Innovative Cancer Therapy
Oncotelic Therapeutics (OTCQB: OTLC) venture Sapu Nano recently secured approval from Australia’s Human Research Ethics Committee…
-
MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) Pioneers Natural Hydrogen Discovery to Fuel Clean Energy Future
This article has been disseminated on behalf of MAX Power Mining Corp. (CSE: MAXX) (OTC:…
-
Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positions Itself in Platinum’s Next Chapter
Disseminated on behalf of Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) and may…